KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $727,803 | +23.4% | 41,900 | 0.0% | 0.00% | – |
| Q2 2023 | $589,952 | +30.9% | 41,900 | 0.0% | 0.00% | – |
| Q1 2023 | $450,844 | -28.2% | 41,900 | 0.0% | 0.00% | – |
| Q4 2022 | $627,662 | +16.7% | 41,900 | 0.0% | 0.00% | – |
| Q3 2022 | $538,000 | +53.3% | 41,900 | +15.7% | 0.00% | – |
| Q2 2022 | $351,000 | +17.8% | 36,200 | +20.7% | 0.00% | – |
| Q1 2022 | $298,000 | -15.3% | 30,000 | +0.3% | 0.00% | – |
| Q4 2021 | $352,000 | +7.0% | 29,900 | +3.5% | 0.00% | – |
| Q3 2021 | $329,000 | -27.5% | 28,900 | -11.3% | 0.00% | – |
| Q2 2021 | $454,000 | +11.5% | 32,600 | +48.2% | 0.00% | – |
| Q1 2021 | $407,000 | -22.5% | 22,000 | -25.9% | 0.00% | – |
| Q4 2020 | $525,000 | +21.0% | 29,700 | +4.9% | 0.00% | – |
| Q3 2020 | $434,000 | -42.3% | 28,300 | -4.1% | 0.00% | – |
| Q2 2020 | $752,000 | +87.5% | 29,500 | +13.9% | 0.00% | – |
| Q1 2020 | $401,000 | +89.2% | 25,900 | +34.9% | 0.00% | – |
| Q4 2019 | $212,000 | +30.1% | 19,200 | 0.0% | 0.00% | – |
| Q3 2019 | $163,000 | -13.3% | 19,200 | +38.1% | 0.00% | – |
| Q2 2019 | $188,000 | -23.9% | 13,900 | +58.0% | 0.00% | – |
| Q4 2018 | $247,000 | – | 8,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |